Inhibition of proteinases with recombinant Eglin c during experimental Escherichia coli septicemia in the pig by Siebeck, Matthias et al.
Vol. 21, 1989 
European 
Surgical Research 
Clinical and Experimental Surgery 
Founded 1969 
Editor-in-Chief 
K. Messmer, Heidelberg 
Editorial Board 
J. Ahonen, Helsinki 
H.G. Beger, Ulm 
R. Benichoux, Luneville 
H. Bismuth, Villejuif 
S.-E. Bergentz, Malmö 
J.L. Berk, Cleveland, Ohio 
R.Y. Calne, Cambridge 
R. Dionigi, Pavia 
U . Haglund, Malmö 
R.O. Heimbecker, 
Collingwood, Ont. 
W.R Klövekorn, Munich 
F. Largiader, Zurich 
M . Lempinen, Helsinki 
D. Loisance, Cr&eil 
R. Lozano, Zaragoza 
H. E. Myrvold, Trondheim 
R. Schosser, Heidelberg 
I . Taylor, Southampton 
R.E. Wilson, Boston, Mass. 
Contents Vol. 21,1989 
No. 1 Original Papers 
Peritoneal Lavage Efficiently Eliminates Protease-Alpha-2-Macroglobulin Complexes and 
Components of the Contact System from the Peritoneal Cavity in Patients with Severe 
Acute Pancreatitis 
Aasen, A.O.; Ruud, T.E.; Roeise, O.; Bouma, B.N.; Stadaas, J.0 1 
Inhibition of Proteinases with Recombinant Eglin C during Experimental Escherichia coli 
Septicemia in the Pig 
Siebeck, M . ; Hoffmann, H. ; Jochum, M . ; Fritz, Η 11 
Improved Survival with Splenic Autotransplantation and Fibronectin Therapy following 
Endotoxin Administration in Rats 
Calise, F.; Capron-Laudereau, M . ; Gugenheim, J.; Pin, M.-L.; Gigou, M . ; Cuomo, O.; 
Reynes, M . ; Bismuth, Η 18 
Magnetic Resonance Imaging in Detecting Acute Oedematous and Haemorrhagic Pancre­
atitis: An Experimental Study in Pigs 
Puolakkainen, P.; Kivisaari, L.; Sipponen, J.; Standertskjöld-Nordenstam, C.-G.; 
Nuutinen, P.; Schöder, Τ 25 
Studies on the Dose Dependence of Endotoxin-Induced in vitro Activation of the Comple­
ment System 
Roeise, O.; Garred, P.; Molines, T.E.; Aasen, A.O. . 34 
Acute Ischemic Liver Failure in the Rat: A Reproducible Model Not Requiring Portal 
Decompression 
Asakawa, H. ; Jeppsson, B.; Mack, P.; Hultberg, B.; Hägerstrand, I . ; Bengmark, S. . . 42 
Effects of Hyperthermochemoradiotherapy on KSE-1 Cells, a Newly Established Human 
Squamous Cell Line Derived from Esophageal Carcinoma 
Matsuoka, H.; Sugimachi, K.; Mori , M . ; Kuwano, H.; Ohno, S.; Nakano, S 49 
Autogenous Skin and Fascia Grafts as Topical Hemostatic Agents in Splenic Injuries 
Eitan, Α.; Munichor, Μ.; Barzilai, A 60 
No. 2 Original Papers 
Long-Term Survival of Kidney Allografts in Dogs after Withdrawal of Immunosuppression 
with Ciclosporin and Azathioprine 
Davies, ff. S.H.; St. John Collier, D.; Thiru, S.; Decurtins, M . ; Calne, R.Y 65 
Restoration of ATP Contents in the Transplanted Liver Closely Relates to Graft Viability 
in Dogs 
Higashi, H. ; Takenaka, K.; Fukuzawa, K.; Yoshida, Y.; Sugimachi, Κ 76 
IV Contents 
Thioacetamide- and Carbon Tetrachloride-Induced Liver Cirrhosis 
Dashti, H. ; Jeppsson, B.; Hägerstrand, I . ; Hultberg, B.; Srinivas, U. ; Abdulla, M. ; Beng-
mark, S 83 
New Intraoperative Biliary Manometric Technique Using a Balloon Catheter - Selective 
Evaluation of Papillary Function 
Kubota, K.; Itoh, T.; Shibayama, K.; Kosuge, T.; Nomura, Y.; Idezuki, Y 92 
Effects of Partial Deprivation of Portal Blood on Arterial Blood Ketone Body Ratio in 
Rabbits 
Yamamoto, S.; Nitta, N . ; Kamiyama, Y.; Yamaoka, Y.; Ozawa, Κ 98 
Primate Cardiac Alio- and Xenotransplantation: Modulation of the Immune Response with 
Photochemotherapy 
Pepino, P.; Berger, C.L.; Fuzesi, L.; Panza, Α.; Pierson, R.N.; Gutierrez, C ; Marboe, 
C.C.; Smith, CR.; Reemtsma, K.; Rose, E.A 105 
Blood Mononuclear Cell Production of IL-1 and IL-2 following Moderate Surgical 
Trauma 
Grzelak, I . ; Olszewski, W.L.; Rowinski, W. 114 
Coronary Artery Plaque Rapidly Induced by Local Electromagnetic Stimulation in the 
Baboon 
Breuer, Η.; Fincham, J.; Hinrichsen, P.; Uys, C.J.; Weich, Η.; Reichart, Β . 123 
No. 3-4 Original Papers 
Disturbances of Reticulo-Endothelial Function following Experimental Liver Transplanta­
tion 
Lahnborg, G.; Bracher, Μ.; Hickman, R.; Terblanche, J 129 
Orthotopic Partial Liver Transplantation in Dogs Can Be Performed without Cold Per­
fusion of the Donor Liver. Evaluation of Its Feasibility in Terms of Energy Metabo­
lism 
Tokunaga, Y.; Zaima, M . ; Tanaka, K.; Maki, Α.; Katayama, T.; Sakai, Y.; Egawa, H.; 
Kiuchi, T.; Yamamoto, Y.; Ueda, J.; Lin, H. ; Kitakado, Y.; Nitta, N . ; Kamiyama, Y.; 
Yamaoka, Y.; Ozawa, Κ 137 
Changes in Serum Bile Acid Composition in Relation to Histological Findings after Liver 
Transplantation in Piglets 
Okanoue, T.; Kimoto, M . ; Maki, Α.; Usui, Y.; Nishimura, N . ; Kobayashi, N . ; Kami­
yama, Y.; Ozawa, Κ . . 145 
Use of Verapamil with Conventional Immunosuppression after Porcine Renal Transplan­
tation 
Kahn, D.; Hickman, R.; Dreyer, C ; Temple Camp, C. 156 
Pancreaticoduodenal Graft in the Rat: An Original Microsurgical Technique 
Benetti, L.; Bassi, C ; Zamboni, G.; Radin, S.; Falconi, M . ; Girelli, R.; Elio, Α.; Briani, 
G.F.; Cavallini, G.; Pederzoli, Ρ 162 
Pressure-Volume Curve of the Remaining Lung after Lung Resection 
Hatakeyama, S.; Harada, K.; Saoyama, N. ; Monden, Y 168 
Morphological and Hemodynamic Changes of the Lung after Injection of 5% Ethanolamine 
Oleate into Dogs 
Iso, Y.; Kitano, S.; Iwanaga, T.; Hashizume, M . ; Sugimachi, Κ 175 
1,2-Dimethylhydrazine-Induced Carcinogenesis Influenced by Different Colonic Anasto­
moses in Rats 
Rokitansky, Α.; Trubel, W.; Buxbaum, P.; Moeschl, Ρ 184 
Contents V 
Famotidine Does Not Inhibit Liver Regeneration 
Kanashima, R.; Kobayashi, Μ 190 
Effect of Preoperative 4'-Epidoxorubicin (Epi-Adriamycin) Treatment on the Regeneration 
and Function of the Liver in Partially Hepatectomized Rats 
Hall, K.S.; Lien, B.; Paulsen, J.E.; Clausen, O.P.F.; Bergan, Α.; Rugstad, H.E 196 
Analysis of Hemodynamics and Blood Gas in Relation to Blood Ketone Body Ratio in 
Partially Hepatectomized Patients 
Nakatani, T.; Shimahara, Y.; Mori, K.; Kobayashi, N . ; Yamaoka, Y.; Kobayashi, K.; 
Ozawa, Κ 205 
Effect of PGh and Thromboxane Antagonist on Liver Ischemic Injury 
Besse, Τ.; Gustin, Τ.; Claeys, Ν.; Schroeyers, P.; Lambotte, L 213 
Revised Model for the Study of Colonic Anastomotic Healing in Protein Malnourished 
Rats 
Law, N.W.; Ellis, Η 218 
Hypoxia Enhances the Lethality of Mitomycin C and Carboquone against Human Malig­
nant Tumor Cells in vitro 
Kusumoto, T.; Maehara, Y.; Sakaguchi, Y.; Saku, M . ; Sugimachi, Κ 224 
Announcements 232 
No. 5 Obituary 
Walter Brendel 233 
Original Papers 
Immunological Treatment with Low Dosage Ciclosporin in Rat Liver Allotransplanta­
tion 
Okamura, R.; Tanaka, K.; Asonuma, K.; Uemoto, S.; Katayama, T.; Tanaka, M . ; 
Utsunomiya, H.; Ozawa, K.; Hoshida, T.; Inui, K.; Hori, R 235 
Effect of Hyperthermia on Isolated Perfused Rat Liver 
Zavagno, G.; Vespa, D.; Moschin, N. ; Belluco, C ; Cecchetto, Α.; Bertocco, E.; Raimondo, 
Α.; Lise, Μ 243 
Extent of Hepatectomy in the Rat. Evaluation of Basal Conditions and Effect of Therapy 
Emond, J.; Capron-Laudereau, M . ; Meriggi, F.; Bernuau, J.; Reynes, M . ; Houssin, D. 251 
Interleukin-2 and Alpha Interferon Therapy of Advanced Pulmonary Metastases 
Kim, B.; Warnaka, P.; Imbembo, A 260 
Preventing Recurrent Postoperative Adhesions: An Experimental Study in Rats 
Verreet, P.R.; Fakir, C ; Ohmann, C ; Röhrer, H.D 267 
Comparison of Cardiopulmonary Variables with Intermittent Positive Pressure Ventilation 
and High-Frequency Jet Ventilation during Abdominal Aortic Operations 
Tabatabai, M . ; Javadi, P.P 274 
Carbon Tetrachloride-Induced Experimental Cirrhosis in the Rat: A Reappraisal of the 
Model 
Ariosto, F.; Riggio, O.; Cantafora, Α.; Colucci, S.; Gaudio, E.; Mechelli, C ; Merli, M. ; 
Seri, S.; Capocaccia, L 280 
Inhibition of Thrombin on Subendothelium. Studies on Rabbit Aorta, ex vivo 
Nydahl, S.; Frebelius, S.; Swedenborg, J 287 
Announcement 296 
V I Contents 
No. 6 Original Papers 
Oxygen Free Radical-Induced Histamine Release during Intestinal Ischemia and Reperfu-
sion 
Boros, Μ.; Kaszaki, J.; Nagy, S 297 
Piroxicam Affects Collagen Changes around Experimental Intestinal Anastomoses 
Mastboom, W.J.B.; Hendriks, Τ.; Elteren, P. van; Boer, H.H.M. de 305 
Multifocal Gastric Cancer in Patients Younger than 50 Years of Age 
Furukawa, H.; Iwanaga, T.; Imaoka, S.; Hiratsuka, M . ; Fukuda, I . ; Kabuto, T.; Ishi-
kawa, O.; Sasaki, Y 313 
Model of Pulmonary Extravasation as an Effect of Neutropenia in Endotoxic Shock in 
Guinea Pigs 
Märtensson, L.; Davidsson, B.; Hultkvist, U 319 
Hemodynamic Effects of Mexiletine and Disopyramide after Cardioplegic Arrest 
Moritz, Α.; Eckersberger, F.; Losert, U . ; Probst, P.; Schreiner, W.; Wolner, Ε 327 
Serial Mixed Lymphocyte Culture Responses in Pigs after Liver or Kidney Auto- or Allo­
transplantation 
Bracher, Μ.; Hickman, R.; Terblanche, J 336 
Rib Fracture Healing after Osteosynthesis with Wire Mesh Titanium and Screws: 
A Histological Study in Sheep 
Klein, C.P.A.T.; Lübbe, H.B.M. van der; Gahr, R.H 347 
Author Index 355 
Subject Index 357 
Suppl. 1 Long Acting Cephalosporins in Surgery 
World Congress of the International College of Surgeons 
Milan, July 3-9, 1988 
Guest Editor: K. Hell, Basel 
Suppl. 2 European Society for Surgical Research 
24th Congress, Brussels 1989 
Abstracts 
Editors: B. de Hemptinne, Brussels; S. Karran, Southampton; L. Lambotte, Brussels 
Eur Surg Res 1989;21:11-17 
© 1989 S. Karger A G , Basel 
0 0 1 4 - 3 1 2 Χ / 8 9 / 0 2 Π - 0 0 1 1 $ 2 . 7 5 / 0 
Inhibition of Proteinases with Recombinant Eglin C during 
Experimental Escherichia coli Septicemia in the Pig 
M. Siebeck*, H. Hoffmann*, M. Jochumh, H. Fritzb 
a Chirurgische Klinik Innenstadt und Chirurgische Poliklinik, und 
b Abteilung für Klinische Chemie und Klinische Biochemie in der Chirurgischen Klinik Innenstadt, 
Ludwig-Maximilians-Universität München, BRD 
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Abstract. Administration of the proteinase inhibitor eglin C reduces the symptoms of 
capillary leakage in a porcine model of septic shock. This was assessed by measurements of 
blood pressure, plasma protein concentration, hematocrit, and duration of urine production. 
Eglin C plasma levels around 1.2 μΜ resulted from a dose of 1.9 mg-kg-^h - 1 for 4 h and 
were therapeutically effective. A higher dose of eglin C (7.7 mg-kg-^h - 1 for 4h) induced 
levels of approximately 5.6 μΜ in plasma and was not superior. This observation indicates 
that lysosomal proteases from neutrophils or degranulation of mast cells play a crucial role in 
the increase of capillary permeability during septicemia. 
Introduction 
Eglin C is a protein proteinase inhibitor 
originally derived from the medical leech 
[10]. It contains 70 amino acid residues in a 
single polypeptide chain without disulfide 
bridges and its relative molecular weight is 
8,100. It is a rapid and potent inhibitor of 
human granulocytic elastase, cathepsin G , 
and chymotrypsin, and it is unusually stable 
against denaturation by heat, acid, and pro­
teolysis. 
In a previous study, we examined possi­
ble pathophysiologic mechanisms in septic 
shock which may be initiated by lysosomal 
proteinases released into the extracellular 
space [4] using r-eglin C in a dose of 3.85 
mg'kg-^h - 1 . The present study was con­
ducted to determine the effect of a higher 
(2-fold increased) and a lower (50% reduced) 
dose of r-eglin C on experimental septicemia 
in a similar model of septic shock. 
Materials and Methods 
A synthetic gene coding for the sequence of 
eglin C was expressed in transformed Escherichia coli 
and the expression product, recombinant eglin C 
(r-eglin C) was purified [9]. r-EglinC was found to 
possess the same inhibitory properties as the natural 
protein from the leech. 
Weaned domestic pigs were purchased from the 
Lehr- und Versuchsgut Oberschleissheim, Veterinary 
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School, University of Munich. The experiments were 
performed with 18 pigs with body weights ranging 
from 17 to 25.5 kg (mean: 19.7 kg). Acepromazine 
maleate, 50 mg, was given intramuscularly for preme-
dication after fasting overnight and anesthesia was 
induced with pentobarbital, 15 mg/kg, given intrave-
nously. Narcosis was maintained by repeated injec-
tions of pentobarbital, 80 mg, as needed. Pentobarbi-
tal injection was avoided during the 10 min preceding 
aortic blood pressure measurements. 
Left groin vessels were cannulated with saline-
filled polyethylene catheters. The blood pressure in 
the aorta was measured with a Bentley Trantec Model 
800 transducer and a Siemens Sirecust 404 monitor. 
Two femoral venous lines were used for infusions. 
Blood was sampled with a short, large bore cannula in 
the left external jugular vein. A suprapubic cystos-
tomy was performed to enable collection of urine. 
The animals were allowed to rest for 60 min after the 
operation and remained in the right lateral position 
during the experiment. They were breathing sponta-
neously room air. 
Al l animals received a suspension of freshly cul-
tured E. coli (014 B26), 3· 10 1 0 cells, as assessed by 
turbidimetry, in 24 ml saline over 2 h. Each animal 
was randomly assigned to 1 of 3 treatment protocols: 
6 animals received E.coli and 0.9% saline, 200 ml, 
and served as controls; 6 animals were given E. coli 
and a 'low' dose of rreglin C, 1.9 mg-kg- 1 -h" 1 ; and 6 
animals E. coli and a 'high' dose of r-eglin C, 7.7 
m g - k g - 1 ' h - 1 . The r-eglin C (or saline) infusion was 
started simultaneously with the E. coli infusion (time 
zero) and was given for 4 h in a volume of 200 ml. 
The output of urine was measured hourly. Anuria 
was diagnosed when the urine production fell below 
3 ml/h. Survival periods and duration of urine pro-
duction were calculated from time zero. The experi-
ments were terminated 24 h after time zero i f death 
due to septic shock was not imminent. Plasma sam-
ples were made as follows: blood was anticoagulated 
with 3.8% citrate 1:10 and centrifuged at 4 ° C at 
3,000 rpm for 20 min. The supernatant was aliquoted 
and stored at - 80 ° C. Arterial blood gas analyses were 
performed with an A V L Gas Check 939 on hepari-
nized samples. Blood for cell counts was anticoagu-
lated with EDTA. Hematocrit was measured with 
microcapillaries and a Hettich Hämatokrit centri-
fuge, hemoglobin was measured with a Coulter Hae-
moglobinometer, white blood cells were counted with 
a Coulter Counter Model D, and platelets in a Neu-
Time, h 
Fig. 1. Cumulative mortality after E. coli and r-
eglin C administration (n = 6 in each group). 
E. coli, 3· 10'° cells + NaCl, 0.9% (control group) (· ·). 
Ε. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg-1 -h" 1 ( A — A ) . 
E. coli, 3· ΙΟ 1 0 cells + r-eglin C, 7.7 mg-kg-1-h"1 (•—-•). 
bauer hemocytometer chamber. r-Eglin C concentra­
tions in plasma were quantitated by a competitive 
enzyme-linked immunosorbent assay [8] using perox-
idase-conjugated eglin and affinity purified anti­
bodies from sheep directed against leech eglin [Mül-
ler-Esterl et al., unpubl. results]. The total protein 
concentration in plasma was measured by the Biuret 
method. Creatinine in plasma was measured kineti-
cally on an automated analyzer using picric acid 
(Merck, Darmstadt). 
Al l data are presented as arithmetic mean ± sam-
ple standard deviation. Survival curves for the events 
death and anuria were analyzed with the generalized 
Mantel-Haenszel test followed by ScheffS type multi-
ple comparisons (a = 0.05). Al l other parameters were 
compared using a one-way analysis of variance fol-
lowed by ScheffS's multiple comparison test with α = 
0.05. For statistical significance testing we selected 
the time 4 h after start of the infusions for two rea­
sons: the eglin infusions were discontinued after 4 h, 
and the case numbers in the three groups declined 
thereafter due to mortality from septicemia. Since 
there was considerable variation of the hematocrit 
starting values between the three groups we selected 
the hourly rate of increase of hematocrit of each indi­
vidual animal during the first 4h , as assessed by 
linear regression over time, as a measure of hemocon-
centration. 
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Time, h 
Fig. 2. Mean aortic pressure after E. coli and 
r-eglin C administration. Means and standard 
deviation. Asterisk indicates a significant (p < 0.05) 
difference from the control group (n = 6 in each 
group). 
E. coli, 3· 1010 cells + NaCl, 0.9% (control group) (· ·). 
Ε. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg^-h- 1 ( A - - A ) . 
Ε. coli, 3· 1010 cells + r-eglin C, 7.7 mg-kg-^h"1 (•-—•). 
0 4 Ö 
Time, h 
Fig. 3. Total protein concentration in plasma after 
E. coli and r-eglin C administration. Means and stan-
dard deviation. Asterisk indicates a significant (p < 
0.05) difference from the control group (n = 6 in each 
group). 
E. coli, 3· 1010 cells + NaCl, 0.9% (control group) (· ·). 
E. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg-'-h"1 ( A — A ) . 
E. coli, 3· 1010 cells + r-eglin C, 7.7 mg-kg-^h"1 (•—-•). 
Results 
Mortality (fig. 1) 
One animal that had received E. coli and 
r-eglin C in the low dose, 1.9 mg-kg-^h - 1 
for 4 h, died after 2 h 40 min of nonseptic 
cardiac failure and was eliminated thereafter 
from anuria analysis. Total mortality due to 
septicemia was 9/17 53%). The 24-hour 
survival rate was 2/6 in the septic reference 
group, 4/5 in the low-dose and 2/6 in the 
high-dose eglin group. 
Arterial Hypotension (fig. 2) 
In nearly all animals a marked reduction 
in mean arterial blood pressure was observed 
at the end of the E. coli infusion. All animals 
of the septic reference group had a severe 
hypotension (a fall in mean aortic pressure 
by more than 25 mm Hg) during the first 4 h. 
Two animals of the low-dose eglin group and 
4 pigs of the high-dose group did not show 
this response. In the surviving animals, a 
recovery of blood pressure was noted, in 
some of them even exceeding the starting 
value. Group means differed significantly af-
ter 4 h with the blood pressure in the septic 
reference group being 20-30 mm Hg lower 
than in the two eglin groups (in the control 
group 63.5 ± 14.7 mm Hg, in the low-dose 
group 84.6 ± 23.7 mm Hg, and 91.2 ± 12.5 
mm Hg in the high-dose group). In the 
Scheffo comparison only the high dose group 
differed significantly from the control 
group. 
Hypoproteinemia (fig. 3) 
The total plasma protein concentration 
decreased steadily in the septic reference 
group from 5.6 ± 0.4 to 4.6 ± 0.5 g/100 ml, 
whereas it remained more or less constant in 
both eglin groups (slight decrease from 5.9 ± 
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0.3 to 5.7 ± 0.5 in the low-dose and from 5.6 
± 0.2 to 5.4 ± 0.2 in the high-dose eglin 
group). Group means differed significantly 
after 4 h with the total plasma protein con­
centration in the septic reference group be­
ing about 0.4 g/100 ml lower than in the two 
eglin groups (in the control group 5.23 ± 
0.26 g/100 ml, in the low-dose eglin group 
5.62 ± 0.28 g/100 ml, and 5.67 ± 0.24 g/100 
ml in the high dose group). In the Scheffo 
comparison only the high-dose group dif­
fered significantly from the control group. 
Hemoconcentration (fig. 4) 
Hematocrit increased rapidly (from 30 ± 
3 to 38 ± 3%) during the first 4 h in the 
septic reference animals. The rise was less 
pronounced under eglin administration 
(from 32 ± 4 to 36 ± 4%). In the septic 
reference animals, the hemoconcentration 
expressed as the mean rate of rise of hemat­
ocrit during the first 4 h by linear regression 
over time was 1.5 ± 0.9% per hour as 
opposed to 0.7 ± 0.5% per hour in all eglin-
treated animals. The hemoglobin concentra­
tions behaved similarly. 
Renal Function 
Figure 5 shows a life table plot for the 
time intervals between time zero and the 
onset of anuria for the three groups. After 
24 h, only 6 of all animals ( = 35%) were not 
anuric: 1/6 ( = 17%) of the septic reference 
animals but 3/5 (^ 60%) and 2/6 (^ 33%) 
of the low- and high-dose eglin-treated pigs, 
respectively. The difference between the 
three groups was not significant. When data 
from both eglin groups were pooled renal 
function was significantly protected (p = 
0.048) when compared to the septic refer­
ence animals by the generalized Mantel-
Haenszel test. Creatinine concentration in 
Fig. 4. Hemoconcentration during the first 4 h of 
E. coli and r-eglin C administration. Abscissa = Ex­
perimental groups; ordinate = hourly rise of hemato­
crit by linear regression over time (%/h) (n = 6 in each 
group). 
E. coli, 3- 1010 cells + NaCl, 0.9% (control group) (·). 
Ε. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg-1 -h" 1 (A). 
E. coli, 3-1010 cells + r-eglin C, 7.7 mg-kg"1 -h" 1 (•). 
plasma increased from 1.06 ± 0.22 mg/100 
ml at time zero to 2.6 ± 1.6 mg/100 ml (last 
available value for each animal). Plasma cre­
atinine concentration was noticeably higher 
in controls than in the other groups after 6 h 
(1.2 ± 0.34 mg/100 ml in the low-dose group 
and 1.26 ± 0.26 mg/100 ml in the high-dose 
group as compared to 1.78 ± 0.29 mg/100 
ml in the control group) and later on. 
Eglin C Plasma Levels (fig. 6) 
Maximum eglin C plasma levels were 9.6 
± 1.3 μg/ml (^ 1.2 μΜ) after 4 h of low-
dose eglin C infusion, 1.9 mg-kg - 1 -h - 1 . In 
the group with the high eglin dose, 7.7 mg* 
k g - ^ h - 1 for 4 h, 5 of 6 animals reached 
maximum plasma levels of 44.7 ± 13.6 μg/ 
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Fig. 5. Cumulative probability plot for the occur­
ence of anuria after E. coli and r-eglin C administra­
tion (n = 6 in each group). 
E. coli, 3· 1010 cells + NaCl, 0.9% (control group) (· ·). 
Ε. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg"1 -h" 1 (A—A) . 
E. coli, 3· 1010 cells + r-eglin C, 7.7 mg-kg-'-h"1 (•-—•). 
Fig. 6. Eglin C concentration in plasma after 
E. coli and r-eglin C administration. Ordinate: eglin C 
concentration in plasma ^ g / m l , logarithmic scale, 
means ± SD) (n = 6 in each group). 
E. coli, 3· 1010 cells + r-eglin C, 1.9 mg-kg-'-h-1 ( A — A ) . 
E. coli, 3-1010 cells + r-eglin C, 7.7 mg-kg-'-h"1 (•—-•). 
ml ( = 5.6 μΜ) and 1 animal ΙΟΟμ^πιΙ. 
The data of this latter experiment were not 
used in figure 6. Eglin plasma levels decayed 
rapidly after the end of the infusion. 
Other Parameters 
White blood cell counts uniformly 
showed a rapid initial decline by 80-90% 
with a minimum after 1-6 h followed by the 
slow development of leukocytosis in all ani­
mals that survived more than 12 h. Details 
on white blood cells and elastase-inhibitor 
complex levels in plasma have been reported 
elsewhere [11]. All animals showed a moder­
ate degree of thrombocytopenia but platelet 
counts below 100,000/μ1 were found in 1 
case only. The decrease was maximum after 
8 h (186,000 ± 71,000/μ1, i.e. 40% of 
459,000 ± 124,000/μ1 before the start of the 
E. coli infusion). The arterial pC>2 of all ani­
mals at baseline was 85.2 ± 8.2 mm Hg. The 
majority of animals (11/18) experienced se­
vere hypoxemia (decrease in arterial ρθ2 by 
more than 30 mm Hg). The arterial pCC>2 of 
all animals at baseline was 38.2 ± 4.2 mm 
Hg. All but 2 animals (both from the high-
dose eglin group) developed hypocapnia (ar­
terial P C O 2 below 32 mm Hg). The respira­
tory rate was 26 ± 11/min at baseline, and 
all but 4 animals developed tachypnea (re­
spiratory rate above 40/min). Acidosis (pH 
in arterial blood) was slightly less pro­
nounced in the eglin-treated animals. 
Discussion 
Treatment of septic pigs with r-eglin C at 
two different dosages prevented a fall in 
blood pressure compared to the nontreated 
controls. Similarly, in a model of traumatic 
shock of the rat an improvement of the 
arterial blood pressure after eglin treatment 
was noted [3]. These findings may indicate 
the inhibition of the action of vasoactive 
mediators (with ensuing vascular smooth 
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muscle relaxation) or of compounds that in­
crease vascular permeability (resulting in hy­
povolemia) or both. Of great importance is 
the observation that r-eglin C also inhibits 
porcine lung mast cell chymase [1]. This pro­
tease is believed to be involved in mast cell 
degranulation [5]. Inhibition of chymase can 
prevent the release of histamine from mast 
cells [6]. Furthermore, cathepsin G and elas-
tase from neutrophils may influence the ara-
chidonic acid cascade and thus play a role in 
vasoregulation [7]. Both enzymes are very 
rapidly and effectively inhibited by eglin C 
[10]. 
The fall in total protein concentration in 
plasma was significantly attenuated in the 
eglin-treated animals. Eglin C apparently 
protected the septic pigs from developing 
hypoproteinemia. Moreover, the control ani­
mals showed more severe hemoconcentra­
tion in their hematocrit values than the 
eglin-treated animals. This supports the view 
that an increase in permeability to protein 
was the primary event leading to subsequent 
loss of fluid from the vascular bed to the 
interstitial space. There is ample evidence 
connecting the action of lysosomal protein­
ases from neutrophils to increased vascular 
permeability [12]. Mainly involved are pep­
tide fragments from large proteins such as 
coagulation and complement factors [13]. 
The influence of r-eglin C on hypovo­
lemia and hypotension following E. coli sep­
ticemia is of great importance for renal func­
tion. However, the effect of r-eglin C treat­
ment on the duration of urine production 
under this condition may also indicate a 
direct effect of lysosomal proteinases on kid­
ney function. It was shown that neutrophils 
stimulated in situ by deposited immune 
complexes digest glomerular basement mem­
brane [14]. Using an enzyme inhibitor, PMN 
elastase and cathepsin G were identified as 
the responsible agents. In 5 of 6 patients suf­
fering from acute renal failure of various ori­
gin, elevated plasma levels of the PMN elas-
tase-alpha-1 -proteinase inhibitor complex 
were observed [2]. In blood smears of these 
patients reduced proteinase activity in gran­
ulocytes was found. Hence, lysosomal pro­
teinases such as elastase and cathepsin G 
might have been involved in the pathogene­
sis of acute renal failure in these patients. 
Although we did not detect statistically 
significant differences between the two eglin-
treated groups, it is interesting to note that 
the animals in the low-dose group had better 
survival (fig. 1) and diuresis (fig. 5) curves 
and less hemoconcentration (fig. 4) than 
those in the high-dose group. We have to 
consider contamination of the recombinant 
gene product r-eglin C with other com­
pounds of bacterial origin as a possible ex­
planation. The batch or r-eglin C used in our 
experiment contained less than 5 ppm endo­
toxin [Schnebli H.P., Basel, Switzerland, 
personal commun.]. It remains questionable 
if such a low amount of endotoxin is able to 
influence the therapeutic effect of eglin C in 
septicemia in the manner that we suspected. 
Toxic effects of a first batch of r-eglin C 
given in a dose of 3.85 mg-kg - 1 -h - 1 were 
clearly due to the presence of minute 
amounts of endotoxin [4]. 
We conclude that r-eglin C at plasma lev­
els between 1 and 5 μιηοΐ/l is able to attenu­
ate in vivo the permeability increase and 
arterial hypotension induced by systemic 
bacteremia in pigs. This indicates that liber­
ated P M N elastase significantly contributes, 
among other factors, to the harmful effects 
precipitated by bacteria in the circulation. 
r-Eglin C might therefore be a useful drug for, 
the. treatment of septic shock in humans. 
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